226 related articles for article (PubMed ID: 6273529)
1. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
Cohen ML; Kurz KD
J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
[No Abstract] [Full Text] [Related]
2. Pharmacological properties of the converting enzyme inhibitor, enalapril maleate (MK-421).
Sweet CS
Fed Proc; 1983 Feb; 42(2):167-70. PubMed ID: 6295819
[TBL] [Abstract][Full Text] [Related]
3. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Takata Y; Di Nicolantonio R; Hutchinson JS
Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
[TBL] [Abstract][Full Text] [Related]
4. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
Jover B; Dupont M; Casellas D; Mimran A
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
[TBL] [Abstract][Full Text] [Related]
5. Comparison in normal volunteers of three converting enzyme inhibitors: RHC 3659, MK 421 and captopril.
Burnier M; Biollaz J; Brunner HR; Turini GA; Gavras H
Am J Cardiol; 1982 Apr; 49(6):1550-1. PubMed ID: 6280484
[No Abstract] [Full Text] [Related]
6. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
[No Abstract] [Full Text] [Related]
7. Relationship between angiotensin I blockade and antihypertensive properties of single doses of MK-421 and captopril in spontaneous and renal hypertensive rats.
Sweet CS; Arbegast PT; Gaul SL; Blaine EH; Gross DM
Eur J Pharmacol; 1981 Dec; 76(2-3):167-76. PubMed ID: 6174351
[TBL] [Abstract][Full Text] [Related]
8. Effect of N-[(S)-1-carboxy-3-phenylpropyl]-L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressor responses in vivo.
Gross DM; Sweet CS; Ulm EH; Backlund EP; Morris AA; Weitz D; Bohn DL; Wenger HC; Vassil TC; Stone CA
J Pharmacol Exp Ther; 1981 Mar; 216(3):552-7. PubMed ID: 6259322
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of pressor responses to intracerebroventricular angiotensin I by angiotensin converting enzyme inhibitors and their effects on systemic blood pressure in conscious rats.
Baum T; Becker FT; Sybertz EJ
Life Sci; 1983 Mar; 32(12):1297-303. PubMed ID: 6300578
[TBL] [Abstract][Full Text] [Related]
10. Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats.
Minsker DH; Bagdon WJ; Robertson RT; Bokelman DL
J Toxicol Environ Health; 1984; 14(5-6):715-22. PubMed ID: 6097696
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
[No Abstract] [Full Text] [Related]
12. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
13. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
[TBL] [Abstract][Full Text] [Related]
15. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
16. Captopril and MK-421: stability on storage, distribution to the central nervous system, and onset of activity.
Cohen ML; Kurz K
Fed Proc; 1983 Feb; 42(2):171-5. PubMed ID: 6295820
[No Abstract] [Full Text] [Related]
17. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
Lazowski J
Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
[No Abstract] [Full Text] [Related]
19. [A new point of attack for the treatment of hypertension; captopril, an orally active inhibitor of the enzymatic conversion of angiotensin I into angiotensin II].
Schalekamp MA; de Bruyn JH; Wenting GJ; Man in 't Veld AJ; Derkx FH
Ned Tijdschr Geneeskd; 1980 Nov; 124(47):1996-2003. PubMed ID: 6255350
[No Abstract] [Full Text] [Related]
20. Comparative effects of captopril and MK 421 on sympathetic function in spontaneously hypertensive rats.
Antonaccio MJ; McGill M
Am J Cardiol; 1982 Apr; 49(6):1533-4. PubMed ID: 6280483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]